EUVIMEDEUVIMED entdecken
Crossref

Multimodal Imaging Guided Synergistically Therapy in Hypoxic Tumor based on α-NaYbF4:Tm@Cu2– x Se@ZnFe2O4-DOX Nanoplatforms Mediated by NIR Light

Qi Cai iD, Yue Li, Xuewei Ba, Piaoping Yang iD

ACS Applied Bio Materials · 2026

DOI: 10.1021/acsabm.6c00663 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2026. Verfasst von Qi Cai und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Materials Science, Qiqihar University, Qiqihar161006, P. R. China. Hauptthemen laut MEDLINE: Doxorubicin, Biocompatible Materials, Multimodal Imaging, Nanoparticles. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Heilongjiang Provincial Education Department General Research Fund, Heilongjiang Provincial Education Department Basic Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aberrant vascularization and uneven vascular distribution stemming from rapid tumor cell proliferation culminate arouse intra-tumoral hypoxia, which substantially compromises the therapeutic response to conventional chemotherapy, as well as photothermal therapy (PTT) and photodynamic therapy (PDT). In this work, we present an innovative α-NaYbF4:Tm@Cu2–xSe@ZnFe2O4-DOX nanoplatform that synergistically integrates PTT, Fenton reaction-enhanced chemodynamic therapy, PDT, and doxorubicin (DOX)-based chemotherapy under 980 nm near-infrared (NIR) light activation and weakly acidic environment-initiation. The 10 nm cubic-phase α-NaYbF4:Tm up-conversion cores were initially synthesized. Subsequently, low atomic number (Z) Cu2–xSe nanocrystal grown as photo-thermal conversion agent demonstrated significantly stronger X-radiation (X-ray) attenuation capabilities and enhanced computed tomography (CT) imaging performance compared to clinically used iopromide. Furthermore, zinc ferrite (ZnFe2O4) shell was obtained in hydrothermal synthesis manner. The 980 nm NIR-excited α-NaYbF4:Tm nanoparticles undergo efficient energy down-conversion, emitting photons that perfectly match the absorption spectrum of ZnFe2O4, thereby maximizing reactive oxygen species (ROS) generation through bandgap-engineered photoconversion. The tumor's glycolytic activity creates a hydrogen peroxide (H2O2)-rich microenvironment, enabling ZnFe2O4-mediated Fenton-like reactions that produce hydroxyl radicals (•OH) radicals, ultimately triggering oxidative damage and apoptotic cell death. It is noted that dual-mode photothermal therapeutic efficacy was achieved by Cu2–xSe and ZnFe2O4 as photothermal nanocrystal with up-conversion luminescence (UCL), magnetic resonance imaging (MRI) and CT multimodal imaging. DOX as anticancer chemotherapeutics was conjugated to form α-NaYbF4:Tm@Cu2–xSe@ZnFe2O4-DOX nanoplatforms. It remains effectively release of large quantities of DOX at tumor part conferred response to excessive lactic and carbonic acids generated in cancer cells. Our research may provide an insight for generalizing enhanced synergetic performance by NIR light-mediated PTT, Fenton reaction, PDT and chemotherapy. It is not a simple assembly of known components, but rather a multi-functional synergistic system constructed through ingenious core-shell structural design, capable of responding to near-infrared light and the tumor microenvironment. For the first time, this system seamlessly integrates up-conversion luminescence-mediated PDT, dual photothermal agent-enhanced PTT, self-supplying H2O2 Fenton reactions, and acid/heat dual-responsive chemotherapy into a single nanoplatform. Additionally, it incorporates multimodal imaging capabilities, providing an innovative and comprehensive solution to overcome the clinical challenge of tumor hypoxia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinBiocompatible MaterialsMultimodal ImagingNanoparticlesAntibiotics, AntineoplasticInfrared RaysAnimalsMaterials TestingHumansPhotochemotherapyMiceParticle SizeCell SurvivalCell ProliferationTumor HypoxiaDrug Screening Assays, Antitumor

Stichwörter der Autor:innen

Cu2–xSeFenton reactionZnFe2O4chemotherapyphotodynamic therapyphotothermal therapy

Substanzen

DoxorubicinBiocompatible MaterialsAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • College of Materials Science, Qiqihar University, Qiqihar161006, P. R. China.
  • Heilongjiang Eye Hospital, Harbin150000, P. R. China.
  • Key Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Material Sciences and Chemical Engineering, Harbin Engineering University, Harbin150001, P. R. China.

ORCID-Profile: Qi Cai, Piaoping Yang

Förderung

  • Heilongjiang Provincial Education Department General Research Fund
  • Heilongjiang Provincial Education Department Basic Research Fund

Zitieren

APA

Cai, Q., Li, Y., Ba, X., & Yang, P. (2026). Multimodal Imaging Guided Synergistically Therapy in Hypoxic Tumor based on α-NaYbF4:Tm@Cu2– x Se@ZnFe2O4-DOX Nanoplatforms Mediated by NIR Light. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c00663

Vancouver

Cai Q, Li Y, Ba X, Yang P. Multimodal Imaging Guided Synergistically Therapy in Hypoxic Tumor based on α-NaYbF4:Tm@Cu2– x Se@ZnFe2O4-DOX Nanoplatforms Mediated by NIR Light. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.6c00663

BibTeX
@article{Cai2026,
  author = {Cai, Qi and Li, Yue and Ba, Xuewei and Yang, Piaoping},
  title = {Multimodal Imaging Guided Synergistically Therapy in Hypoxic Tumor based on α-NaYbF4:Tm@Cu2– x Se@ZnFe2O4-DOX Nanoplatforms Mediated by NIR Light},
  journal = {ACS Applied Bio Materials},
  year = {2026},
  doi = {10.1021/acsabm.6c00663}
}
Kostenlos starten →